Identification of PLOD3 and LRRN3 as potential biomarkers for Parkinson’s disease based on integrative analysis
Abstract Parkinson’s disease (PD) is one of the most prevalent movement disorders and its diagnosis relies heavily on the typical clinical manifestations in the late stages. This study aims to screen and identify biomarkers of PD for earlier intervention. We performed a differential analysis of post...
Main Authors: | Xing Guo, Wenjun Hu, Zijie Gao, Yang Fan, Qianqian Wu, Weiguo Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-05-01
|
Series: | npj Parkinson's Disease |
Online Access: | https://doi.org/10.1038/s41531-023-00527-8 |
Similar Items
-
PB1798: EVALUATION OF EXPRESSION OF PLODS FAMILY GENES (PLOD1, PLOD2, PLOD3) IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
by: F. Zaker, et al.
Published: (2022-06-01) -
Identification and Validation of PLOD2 as an Adverse Prognostic Biomarker for Oral Squamous Cell Carcinoma
by: Yawei Sun, et al.
Published: (2021-12-01) -
Identification of potential diagnostic biomarkers for Parkinson's disease
by: Fenghua Jiang, et al.
Published: (2019-08-01) -
PLODs: Novel prognostic biomarkers and potential immunotherapy targets for head and neck squamous cell carcinoma
by: Siming Gong, et al.
Published: (2023-02-01) -
Up‐regulated LRRN2 expression as a marker for graft quality in living donor liver transplantation
by: Takahiro Tomiyama, et al.
Published: (2022-10-01)